Objectives: Staphylococcus aureus (S.a) is a major cause of pulmonary infection in CF patients. In order to survey the status at the CF centre in Gothenburg concerning the prevalence, persistence and the incidence of patient transmission of S.a we have for the first time performed genotyping of S.a isolates. Methods: S.a isolated from 82 CF patients, aged 3−56 years, were collected between 2011 until 2012. All isolates were determined as MSSA. Of the CF patients included, 34 patients had provided 2 isolates with at least 6 months in-between during the study period. The chosen 68 S.a isolates were genotyped using the spamethod. Briefly, the variable region of protein A was sequenced and the spa-types were determined with Ridom StaphType software and type codes were assigned. Results: We identified 39 different spa-types in the analysed collection. The most common spa-type was t021 (n = 3), which is described as a widespread clone. Strain pairs from 14 patients (41%) showed identical spa-types over time and 13 patients (38%) showed different spa-types which however not exclude the co-existence of the first identified type. From 6 patients only one S.a isolate was able to be genotyped, and for the isolates from one CF patient we were not able to get a spa-type at all. These isolates could be new strains of S.a with different molecular properties. Conclusion: The population structure of S.a isolates recovered from Gothenburg CF centre patients was investigated by spa typing and showed high genotypic diversity.
Objectives: Non tuberculous mycobacteria (NTM) is becoming an increasingly common, serious problem in CF care and risk factors remain uncertain. We interrogated the UK CF Registry to investigate predictors. Methods: All patients in England born after 1980 with a first report of NTM between 2008 and 2012 (cases) were matched with 2 controls without reported NTM from 2007 onwards for age (±6 months), sex and genotype (Homozygous DF508 versus the rest). Results: 340 cases were matched to 680 controls. Reported cases rose 330% from 27 in 2008 to 116 in 2012. Compared with entire 2012 UK CF registry population, 50% of the NTM cases were male (cf 53%, 58% were DF508 homozygous (cf 53%) and 33% were 15 years or younger (cf 42%). A preliminary conditional logistic model to half the dataset was developed. The model considered age, centre of care and the English Index of Multiple Deprivation quintile at isolation together with factors reported from the year BEFORE NTM isolation (CF diabetes, oral/inhaled steroid use, ABPA diagnosis, long term macrolide/azithromycin use and IV antibiotic use > or 14 days). The final model included ABPA diagnosis, inhaled corticosteroid use and IV antibiotic use, but only the latter proved statistically significant (OR=1.89, 95% CI 1.24-2.90). Conclusion: In our modelling dataset, only IV antibiotic use >14 days the previous year was significantly associated with new reporting of NTM and the origins of NTM remain unclear. We now aim to explore the ability of this model to predict NTM in the other half of the cohort − our testing dataset.
Low prevalence of non-tuberculous mycobacteria (NTM) in a referral CF center in Brazil: methodological limitation or reality?
T. Background: The occurrence of common clones of M. abscessus (MA) has been reported from a large UK CF Centre. As the prevalence of MA in our own Adult and Paediatric Units had increased we arranged for all our isolates to be typed. Methods: All current attendees to the Leeds Adult and Paediatric Units who had grown MA on at least one occasion were identified. MA was cultured using a commercial liquid culture system and was confirmed by molecular methods at a Mycobacteriology Reference Laboratory. All confirmed isolates were typed at the Central Public Health Laboratory (Colindale, London) using Variable Number Tandem Repeat (VNTR). Results: MA was identified from 37 patients with CF (25 adults, 12 children). Fifteen patients (eight adults, seven children) shared the same VNTR profile (referred to as Cluster I, ST26 lineage); four patients (all adults) shared another VNTR profile (referred to as Cluster II, ST1 lineage); two adults shared a very similar VNTR profile and the remaining 16 patients (11 adults, 5 children) each had their own unique VNTR profile. Extensive epidemiological investigations were unable to identify clear links between those patients sharing the same VNTR profile. Water testing conducted in the Paediatric CF Unit was negative. Although both units had already adopted strict segregation policies before the emergence of this problem, further measures have been introduced in line with recent UK CF Trust guidance. Conclusion: This report provides further evidence of the clonal dissemination of MA among CF patients. The mechanism is unclear. CF units should undertake typing of MA and review infection prevention measures as a matter of urgency.
